Who Is The Former Pharma Exec Trump Nominated To Lead HHS?

Share

Even President Trump says so.

President Donald Trump will nominate former pharmaceutical executive and industry lobbyist Alex Azar to the top post at the Department of Health and Human Services, according to news reports. "He had full responsibility as deputy secretary for the regulatory processes at HHS".

Trump famously said pharma is "getting away with murder", and previously crossed party lines to endorse Medicare price negotiations.

Azar spent a decade at Lilly before he stepped down to run a pharmaceutical consulting firm earlier this year. More recently, Azar served in many roles with Eli Lilly and Company, an global pharmaceutical company, where as President of Lilly USA, he oversaw the substantial rise in drug prices while simultaneously serving on the board for the world's largest pharmaceutical lobby, Biotechnology Innovation Organization.

Watch Series 3 Helps Apple Inc. Reclaim Its Wearables Crown
Despite the late launch in the period, a quarter of the total Apple Watches sold were LTE S3 Apple Watch models. Despite strong shipments, the Apple Watch Series 3 did not reach its full potential in Q3.

"I will carefully review Mr. Azar's nomination for this critically important position", said Donnelly in a statement. Former George W Bush appointee and industry insider Alex Azar is the most recent swamp creature to emerge from the MAGA train.

Azar's nomination for HHS Secretary follows the ascendance of Seema Verma, who now leads the Centers for Medicare and Medicaid, and former State Health Commissioner Jerome Adams, who became Surgeon General this summer.

Azar has argued against drug price controls in the past, Weissman said at the time, making it "highly unlikely" he would "advance real reform" on the issue.

Share